Back
United Therapeutics Corp. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
UTHR
United Therapeutics Corp.
Last Price:
$513.63
Seasonality Move:
5.61%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing slight selling pressure.
United Therapeutics Corp. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 503.96 | Buy |
| 20-day SMA: | 490.91 | Buy |
| 50-day SMA: | 464.14 | Buy |
| 200-day SMA: | 359.17 | Buy |
| 8-day EMA: | 325.13 | Buy |
| 20-day EMA: | 169.06 | Buy |
| 50-day EMA: | 75.76 | Buy |
| 200-day EMA: | 20.09 | Buy |
United Therapeutics Corp. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 114.06 | Buy |
| Relative Strength Index (14 RSI): | 69.91 | Buy |
| Chaikin Money Flow: | -123456 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (474.65 - 500.77) | Buy |
| Bollinger Bands (100): | (353.09 - 483.11) | Buy |
United Therapeutics Corp. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for United Therapeutics Corp. Stock
Is United Therapeutics Corp. Stock a Buy?
-
United Therapeutics Corp. share price is 513.79 while UTHR 8-day simple moving average is 503.96, which is a Buy signal.
-
The stock price of UTHR is 513.79 while United Therapeutics Corp. 20-day SMA is 490.91, which makes it a Buy.
-
United Therapeutics Corp. 50-day simple moving average is 464.14 while UTHR share price is 513.79, making it a Buy technically.
-
UTHR stock price is 513.79 and United Therapeutics Corp. 200-day simple moving average is 359.17, creating a Buy signal.
UTHR Technical Analysis vs Fundamental Analysis
Buy
59
United Therapeutics Corp. (UTHR)
is a Buy
Is United Therapeutics Corp. a Buy or a Sell?
-
United Therapeutics Corp. stock is rated a BuyThe current United Therapeutics Corp. [UTHR] share price is $513.79. The Score for UTHR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
United Therapeutics Corp. Stock Info
Market Cap:
22.1B
Price in USD:
513.79
Share Volume:
411K
United Therapeutics Corp. 52-Week Range
52-Week High:
519.65
52-Week Low:
266.98
Buy
59
United Therapeutics Corp. (UTHR)
is a Buy
United Therapeutics Corp. Share Price Forecast
-
What is the United Therapeutics Corp. stock price today?The United Therapeutics Corp. stock price is 513.79 USD today.
-
Will UTHR stock go up or go down?United Therapeutics Corp.> share price is forecast to RISE/FALL based on technical indicators
-
Is United Therapeutics Corp. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics Corp. is not overvalued.
Is United Therapeutics Corp. Stock a Buy?
-
United Therapeutics Corp. share price is 513.79 while UTHR 8-day exponential moving average is 325.13, which is a Buy signal.
-
The stock price of UTHR is 513.79 while United Therapeutics Corp. 20-day EMA is 169.06, which makes it a Buy.
-
United Therapeutics Corp. 50-day exponential moving average is 75.76 while UTHR share price is 513.79, making it a Buy technically.
-
UTHR stock price is 513.79 and United Therapeutics Corp. 200-day simple moving average is 20.09, creating a Buy signal.
Fundamental Analysis of United Therapeutics Corp.
Is United Therapeutics Corp. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.90 per share, and an increase next year of $1.85 per share.
Technical Analysis of United Therapeutics Corp.
Should I short United Therapeutics Corp. stock?
-
UTHR Moving Average Covergence Divergence (MACD) indicator is 114.06, suggesting United Therapeutics Corp. is a Buy
-
United Therapeutics Corp. Relative Strength Index (RSI) is 69.91, which suggest United Therapeutics Corp. is overbought
-
The Bollinger Bands (25) for United Therapeutics Corp. is (474.65 - 500.77), which suggest United Therapeutics Corp. is a Buy
-
The Bollinger Bands (100) for United Therapeutics Corp. is (353.09 - 483.11), which suggest United Therapeutics Corp. is a Buy
* United Therapeutics Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.